Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Multistate population and whole genome sequence based strain surveillance of invasive pneumococci recovered in the United States during 2017.

Varghese J, Chochua S, Tran T, Walker H, Li Z, Snippes Vagnone PM, Lynfield R, McGee L, Li Y, Metcalf B, Pilishvili T, Beall B.

Clin Microbiol Infect. 2019 Sep 16. pii: S1198-743X(19)30493-8. doi: 10.1016/j.cmi.2019.09.008. [Epub ahead of print]

2.

A Population-Based Descriptive Atlas of Invasive Pneumococcal Strains Recovered Within the U.S. During 2015-2016.

Beall B, Chochua S, Gertz RE Jr, Li Y, Li Z, McGee L, Metcalf BJ, Ricaldi J, Tran T, Walker H, Pilishvili T.

Front Microbiol. 2018 Nov 19;9:2670. doi: 10.3389/fmicb.2018.02670. eCollection 2018.

3.

Strain features and distributions in pneumococci from children with invasive disease before and after 13-valent conjugate vaccine implementation in the USA.

Metcalf BJ, Gertz RE Jr, Gladstone RA, Walker H, Sherwood LK, Jackson D, Li Z, Law C, Hawkins PA, Chochua S, Sheth M, Rayamajhi N, Bentley SD, Kim L, Whitney CG, McGee L, Beall B; Active Bacterial Core surveillance team.

Clin Microbiol Infect. 2016 Jan;22(1):60.e9-60.e29. doi: 10.1016/j.cmi.2015.08.027. Epub 2015 Sep 10.

4.

Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: an international whole-genome sequencing study.

Lo SW, Gladstone RA, van Tonder AJ, Lees JA, du Plessis M, Benisty R, Givon-Lavi N, Hawkins PA, Cornick JE, Kwambana-Adams B, Law PY, Ho PL, Antonio M, Everett DB, Dagan R, von Gottberg A, Klugman KP, McGee L, Breiman RF, Bentley SD; Global Pneumococcal Sequencing Consortium.

Lancet Infect Dis. 2019 Jul;19(7):759-769. doi: 10.1016/S1473-3099(19)30297-X. Epub 2019 Jun 10.

5.
6.

Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction of 13-valent conjugate vaccine in a nationwide surveillance study conducted in Japan in 2012-2014.

Nakano S, Fujisawa T, Ito Y, Chang B, Suga S, Noguchi T, Yamamoto M, Matsumura Y, Nagao M, Takakura S, Ohnishi M, Ihara T, Ichiyama S.

Vaccine. 2016 Jan 2;34(1):67-76. doi: 10.1016/j.vaccine.2015.11.015. Epub 2015 Nov 19.

7.

The Effect of 13-Valent Pneumococcal Conjugate Vaccine on the Serotype Distribution and Antibiotic Resistance Profiles in Children With Invasive Pneumococcal Disease.

Gaviria-Agudelo CL, Jordan-Villegas A, Garcia C, McCracken GH Jr.

J Pediatric Infect Dis Soc. 2017 Sep 1;6(3):253-259. doi: 10.1093/jpids/piw005.

PMID:
26907814
8.

Epidemiology of invasive pneumococcal disease in older people in Spain (2007-2009): implications for future vaccination strategies.

Ardanuy C, Marimón JM, Calatayud L, Giménez M, Alonso M, Grau I, Pallarés R, Pérez-Trallero E, Liñares J.

PLoS One. 2012;7(8):e43619. doi: 10.1371/journal.pone.0043619. Epub 2012 Aug 22.

9.

Emergence of Multidrug-Resistant Pneumococcal Serotype 35B among Children in the United States.

Olarte L, Kaplan SL, Barson WJ, Romero JR, Lin PL, Tan TQ, Hoffman JA, Bradley JS, Givner LB, Mason EO, Hultén KG.

J Clin Microbiol. 2017 Mar;55(3):724-734. doi: 10.1128/JCM.01778-16. Epub 2016 Nov 9.

10.

Pneumococcal carriage and invasive disease in children before introduction of the 13-valent conjugate vaccine: comparison with the era before 7-valent conjugate vaccine.

Sharma D, Baughman W, Holst A, Thomas S, Jackson D, da Gloria Carvalho M, Beall B, Satola S, Jerris R, Jain S, Farley MM, Nuorti JP.

Pediatr Infect Dis J. 2013 Feb;32(2):e45-53. doi: 10.1097/INF.0b013e3182788fdd.

PMID:
23080290
11.

Decreased Carriage and Genetic Shifts in the Streptococcus pneumoniae Population After Changing the Seven-valent to the Thirteen-valent Pneumococcal Vaccine in Norway.

Steens A, Caugant DA, Aaberge IS, Vestrheim DF.

Pediatr Infect Dis J. 2015 Aug;34(8):875-83. doi: 10.1097/INF.0000000000000751.

PMID:
26020410
12.

Decline in Pneumococcal Nasopharyngeal Carriage of Vaccine Serotypes After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Children in Atlanta, Georgia.

Desai AP, Sharma D, Crispell EK, Baughman W, Thomas S, Tunali A, Sherwood L, Zmitrovich A, Jerris R, Satola SW, Beall B, Moore MR, Jain S, Farley MM.

Pediatr Infect Dis J. 2015 Nov;34(11):1168-74. doi: 10.1097/INF.0000000000000849.

PMID:
26226445
13.

Direct effect of the 13-valent pneumococcal conjugate vaccine use on pneumococcal colonization among children in Brazil.

Neves FPG, Cardoso NT, Cardoso CAA, Teixeira LM, Riley LW.

Vaccine. 2019 Aug 23;37(36):5265-5269. doi: 10.1016/j.vaccine.2019.07.056. Epub 2019 Jul 20.

PMID:
31337592
14.

Invasive Serotype 35B Pneumococci Including an Expanding Serotype Switch Lineage, United States, 2015-2016.

Chochua S, Metcalf BJ, Li Z, Walker H, Tran T, McGee L, Beall B.

Emerg Infect Dis. 2017 Jun;23(6):922-930. doi: 10.3201/eid2306.170071. Erratum in: Emerg Infect Dis. 2017 Oct;23(10):1762.

15.

Invasive Pneumococcal Disease in Children's Hospitals: 2014-2017.

Kaplan SL, Barson WJ, Lin PL, Romero JR, Bradley JS, Tan TQ, Pannaraj PS, Givner LB, Hulten KG.

Pediatrics. 2019 Sep;144(3). pii: e20190567. doi: 10.1542/peds.2019-0567. Epub 2019 Aug 16.

PMID:
31420369
16.

Impact of the introduction of a 13-valent pneumococcal vaccine on pneumococcal serotypes in non-invasive isolates from 2007 to 2016 at a teaching hospital in Japan.

Suzuki S, Osato R, Wajima T, Hasebe T, Ishikawa H, Mitsumori H, Nakaminami H, Noguchi N.

J Med Microbiol. 2019 Jun;68(6):903-909. doi: 10.1099/jmm.0.000992. Epub 2019 May 15.

PMID:
31090535
17.

Population structure of Streptococcus pneumoniae colonizing children before and after universal use of pneumococcal conjugate vaccines in Brazil: emergence and expansion of the MDR serotype 6C-CC386 lineage.

Neves FPG, Cardoso NT, Souza ARV, Snyder RE, Marlow MM, Pinto TCA, Teixeira LM, Riley LW.

J Antimicrob Chemother. 2018 May 1;73(5):1206-1212. doi: 10.1093/jac/dky001.

PMID:
29401243
18.

The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A.

Cooper D, Yu X, Sidhu M, Nahm MH, Fernsten P, Jansen KU.

Vaccine. 2011 Sep 22;29(41):7207-11. doi: 10.1016/j.vaccine.2011.06.056. Epub 2011 Jul 18.

19.
20.

Evolution of Penicillin Non-susceptibility Among Streptococcus pneumoniae Isolates Recovered From Asymptomatic Carriage and Invasive Disease Over 25 years in Brazil, 1990-2014.

Pinto TCA, Neves FPG, Souza ARV, Oliveira LMA, Costa NS, Castro LFS, Mendonça-Souza CRV, Peralta JM, Teixeira LM.

Front Microbiol. 2019 Mar 14;10:486. doi: 10.3389/fmicb.2019.00486. eCollection 2019.

Supplemental Content

Support Center